With increased availability of molecular genetic testing, a wider spectrum of pathogenic variants and clinical findings associated with CACNA1C-related disorders has been recognized such as neurodevelopmental abnormalities and epilepsy, in the absence of classic features of Timothy syndrome or long-QT syndrome [15]. This evidence concerns the gene CACNA1C and epilepsy.